Citigroup Upgrades Anthera Pharmaceuticals To Neutral
May 12, 2015 at 08:56 AM EDT
Citigroup upgraded Anthera Pharmaceuticals Inc (NASDAQ: ANTH) from Sell to Neutral. Anthera Pharmaceuticals shares have gained 65.31 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.